共 16 条
[1]
Rosa FW, Wilk AL, Kelsey FO., Teratogen Update: Vitamin A Congeners, Teratology, 33, pp. 355-364, (1986)
[2]
Rosa FW., Teratogenicity of isotretinoin, (Letter) Lancet, 2, (1983)
[3]
Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Et al., N, Engl J Med, 313, pp. 837-841, (1985)
[4]
Ayme S, Julian C, Gambarelli D, Marotti B, Maurin N., Isotretinoin dose and teratogenicity. (Letter), Lancet, 1, (1988)
[5]
Dai WS, LaBraico JM, Stem RS., Epidemiology of isotretinoin exposure during pregnancy, J Am Acad Dermatol, 26, pp. 599-606, (1992)
[6]
Bigby M, Stem RS, Adverse reactions to isotretinoin, J Am Acad Dermatol, 18, pp. 543-552, (1988)
[7]
Hogan DJ, Strand LM, Lane PR., Isotretinoin therapy for acne: a population based study, Can Med Assoc J, 138, pp. 47-50, (1988)
[8]
Lancaster PAL, Rogers JG., Isotretinoin use in pregnancy (Letter), Med J Aust, 148, pp. 654-655, (1988)
[9]
Annual Reports for the years 1985–1993
[10]
Lee M, Cooper A., Survey of Australian Isotretinoin Prescribing, Australas J Dermatol, 32, pp. 13-16, (1991)